abstract |
A pharmaceutical composition for treating a disease caused by virus comprisingn (A) an antiviral agent lacking inhibitory activity (1) against a cell-to-cell infection through cell fusion from a virus infected cell to an uninfected cell and/or (2) against adsorption of a virus to a target cell, and (B) a compound possessing cell fusion inhibitory activity and/or virus-adsorption inhibitory activity, said antiviral agent and compound being administered in respective amounts so that the combined dosage thereof is effective to treat said disease. |